Description

4-Cyclohexyl-n-(7-Hydroxy-5-Methyl-2-Propyl[1,2,4]Triazolo[1,5-A]Pyrimidin-6-Yl)Benzenesulfonamide is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is valued for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring targeted molecular design. It is essential for research institutions and pharmaceutical manufacturers engaged in the development of new drug candidates, especially within medicinal chemistry and process R&D.

Application

• Pharmaceutical Intermediate: Serves as a key precursor in the synthesis of novel drug candidates, particularly for central nervous system (CNS) or metabolic disorder targets.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization programs in academic and industrial R&D labs.
• Process Development: Employed in scaling up synthetic routes from laboratory to pilot plant and commercial manufacturing scales.
• Reference Standard: Provides a high-purity compound for analytical method development, validation, and quality control testing.
• Biochemical Tool Compound: May be utilized in vitro to study specific enzyme inhibition or receptor binding activities.
• Custom Synthesis Building Block: Used by fine chemical suppliers for the contract manufacturing of more complex, proprietary molecules.

Basic Information

Product Name	4-Cyclohexyl-n-(7-Hydroxy-5-Methyl-2-Propyl[1,2,4]Triazolo[1,5-A]Pyrimidin-6-Yl)Benzenesulfonamide
CAS No.	901230-11-3
Molecular Formula	C21H27N5O3S
Molecular Weight	429.54 g/mol
Synonyms	4-Cyclohexyl-N-(7-hydroxy-5-methyl-2-propyl-[1,2,4]triazolo[1,5-a]pyrimidin-6-yl)benzenesulfonamide; 901230-11-3; 4-Cyclohexylbenzenesulfonamide, N-(7-hydroxy-5-methyl-2-propyl[1,2,4]triazolo[1,5-a]pyrimidin-6-yl)-; 6-[[(4-Cyclohexylphenyl)sulfonyl]amino]-5-methyl-2-propyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-ol; CTK8G6688; AKOS040759623; ZINC000257840509; DB08299
EINECS	Contact for details

Quality Control

Our 4-Cyclohexyl-n-(7-Hydroxy-5-Methyl-2-Propyl[1,2,4]Triazolo[1,5-A]Pyrimidin-6-Yl)Benzenesulfonamide is manufactured under a strict quality management system. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the stringent requirements for pharmaceutical R&D. A detailed Certificate of Analysis (COA) is provided with every shipment, documenting batch-specific results.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). The compound may be hygroscopic; therefore, the container should be kept tightly sealed in a dry environment to prevent moisture uptake.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.